We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Three studies showed that adults aged 20 to 50 years ...

While Europe and Asia have had Stellest glasses for years, the FDA finally approved them for the U.S. in 2025.

Prior to this approval, the only other device indicated for slowing pediatric myopia progression was a contact lens. The Food and Drug Administration (FDA) has cleared the Essilor Stellest eyeglass ...

Please provide your email address to receive an email when new articles are posted on . Spectacle lenses with aspheric lenslets, also known as the Essilor Stellest lenses, were found to significantly ...

The FDA has approved MiSight contact lens, the first contact lens indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at ...

Children and adolescents were at higher risk for myopic maculopathy progression if they had worse best-corrected visual acuity and longer axial length, among other risk factors. Myopic maculopathy ...

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...

CNW/ - CooperVision Canada is proud to announce its sponsorship and partnership with Nikita Ciudin, an elite sprint canoe ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

Glasses to stop myopia or nearsightedness in children have been shown to work in a multi-site trial of 256 children and will go on sale later this year outside the United States. The glasses are the ...

In a new consensus report, the National Academies of Sciences, Engineering, and Medicine said that myopia should be classified as a disease that requires a medical diagnosis, and that children should ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...